6th Annual Dry AMD & GA Therapeutics Summit

Topics

• Next generation in vitro & in vivo preclinical models to supercharge dry AMD disease recapitulation
• Spearheading development to accelerate the next generation of dry AMD & GA therapeutics
• Implementing novel functional endpoints to optimize clinical trial design & accelerate approvals in dry AMD
• Utilising genomics & proteomics studies to accelerate target identification & validation for early therapeutic intervention
• Novel treatment modalities to reduce injection frequency & retinal inflammation
• Accelerating longer lasting, less invasive & precise retinal drug delivery for improved patient compliance in aging population
• Utilizing gene and cell therapy to maintain RPE health in aging patient populations